+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2019-2023)

  • ID: 4758509
  • Report
  • Region: Global
  • 99 Pages
  • Koncept Analytics
1 of 5

FEATURED COMPANIES

  • Eli Lilly and Company
  • Novartis International AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • MORE

Human Growth Hormone (hGH) is a peptide hormone produced by the pituitary gland that stimulates growth in children and adults. It plays an important role in the functioning of the human body by regulating body fluids, muscle and bone growth and fat metabolism of the body. The deficiency of growth hormone in the body is known as growth hormone deficiency which is administered by intramuscular or subcutaneous GH injections on a daily basis. Various therapeutics products are currently in the final phase of development and are expected to be launched in the coming years.

The market is expected to experience robust growth due to the increasing prevalence of GH and long-acting growth hormone formulations in development. Rising aging population accompanied by high growth of serious chronic diseases would keep the demand for hGH drugs high and would act as the growth catalyst for the global market.

The global long-acting growth hormone market is estimated to increase at a commendable rate in future, which is mainly due to increase in research and development activities and increasing occurrence of pituitary dysfunction. TransCon is expected to dominate the market due to ease of use and high efficacy. The market will see a shift in the use of long-acting hormone drugs from daily basis products, positively impacting the market.

Geographically, the U.S. dominated the market owing to its advance healthcare infrastructure. Majority of the players are based in the U.S., thus leading to the highest revenue from this region. The U.S. human growth hormone market is anticipated to grow at a steady rate owing to high research and development efforts.

The report “Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2019-2023)” analyzes the development of this market along with the market opportunities. The four major players: Novartis Ag, Pfizer Inc., Eli Lilly and Company, and Novo Nordisk A/S have been profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global market along with the study of the regional markets.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Eli Lilly and Company
  • Novartis International AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • MORE

1. Overview
1.1 Human Growth Hormone
1.2 Physiological Effects of hGH
1.3 GH Deficiency (GHD)
1.4 Recombinant Human Growth Hormone (rhGH)
1.5 hGH Market by Indications

2. Global hGH Market
2.1 Global hGH Market by Value
2.2 Global hGH Market Forecast by Value
2.3 Global hGH Market by Volume
2.4 Global hGH Market Forecast by Volume
2.5 Global hGH Market Share by Indication
2.6 Global hGH Market by Indication
2.6.1 Global Pediatric GHD Market Forecast by Value (2018-2023)
2.6.2 Global Other GHD Market Forecast by Value (2018-2023)
2.7 Global hGH Market Forecast by Therapeutics
2.7.1 Global TransCon GH Revenue Forecast by Value
2.7.2 Global Other LAGH Market Forecast by Value
2.8 Global hGH Market Forecast by Therapeutics
2.9 Global hGH Market by Therapeutics
2.10 Global hGH Market by Region

3. Regional Markets
3.1 The U.S.
3.1.1 The U.S. hGH Market Forecast by Value
3.1.2 The U.S. hGH Market by Indication
3.1.3 The U.S. Pediatric GH Market Forecast by Value
3.1.4 The U.S. Pediatric GH Market by Indication
3.1.5 The U.S. Pediatric GHD Market Forecast by Value
3.1.6 The U.S. Other Pediatric Indications Market Forecast by Value
3.1.7 The U.S. Adult GHD Market Forecast by Value
3.1.8 The U.S. Adult GHD Market Forecast by Value
3.1.9 The U.S. Pediatric GHD Patient Population Forecast
3.1.10 The U.S. Pediatric GHD Patient Population by Type
3.1.11 The U.S. TransCon Revenue Forecast
3.2 Europe
3.2.1 Europe hGH Market Forecast by Value
3.2.2 Europe hGH Market by Indication
3.2.3 Europe Pediatric GHD Patient Population Forecast
3.2.4 Europe Pediatric GHD Patient Population by Type
3.2.5 Europe TransCon Revenue Forecast
3.3 Japan
3.3.1 Japan hGH Market Forecast by Value
3.3.2 Japan hGH Market by Indication
3.3.3 Japan Pediatric GHD Patient Population Forecast
3.3.4 Japan Pediatric GHD Patient Population by Type
3.3.5 Japan TransCon Revenue Forecast

4. Global Human Growth Hormone Market Opportunity
4.1 VRS-317
4.1.1 VRS-317 – The U.S. Growth Hormone Deficiency Market
4.1.2 VRS-317 – European Union (EU) Growth Hormone Deficiency Market
4.1.3 VRS-317 –Japan Growth Hormone Deficiency Market
4.2 TransCon hGH
4.2.1 TransCon hGH –The US, Europe and Japan/ROW Growth Hormone Deficiency Market
4.2.2 Clinical Development Timeline for TransCon hGH

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Incidence of Cancer Cases
5.1.2 Rise in GDP Per Capita
5.1.3 Increased Spending on Medicines
5.1.4 Increasing Global Healthcare Expenditure
5.1.5 Long-Acting hGH Agents in Development
5.1.6 Increasing Pituitary Dysfunctional Cases
5.2 Trends & Development
5.2.1 Use of TransCon Technology
5.2.2 Development of Auto-Injectors
5.2.3 Use of hGH as an Anti-Aging Therapy
5.3 Challenges
5.3.1 High Cost of Treatment
5.3.2 High R&D Costs
5.3.3 Side Effects of rhGH
5.3.4 Low Share of Biosimilar

6. Competitive Landscape
6.1 Global hGH Market
6.1.1 Global hGH Market Volume Share by Company
6.1.2 Global Long-Acting Growth Hormone Landscape by Company
6.2 The U.S. hGH Market
6.2.1 The U.S. hGH Market Value Share by Company

7. Company Profiles
7.1 Novartis International AG
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Pfizer, Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Eli Lilly and Company
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Novo Nordisk A/S
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies

List of Figures

  • hGH Secretion Control
  • hGH’s Physiological Effect
  • hGH Market Segmentation by Indication
  • Global hGH Market by Value (2014-2018)
  • Global hGH Market Forecast by Value (2019-2023)
  • Global hGH Market by Volume (2014-2018)
  • Global hGH Market Forecast by Volume (2019-2023)
  • Global hGH Market Share by Indication (2018)
  • Global Pediatric GHD Market Forecast by Value (2018-2023)
  • Global Other GHD Market Forecast by Value (2018-2023)
  • Global TransCon GH Revenue Forecast by Value (2022-2028)
  • Global Other LAGH Market Forecast by Value (2022-2028)
  • Global hGH Market Forecast by Therapeutics (2028)
  • Global hGH Market Share by Daily Agents (2018)
  • Global hGH Market by Region (2018)
  • The U.S. hGH Market Forecast by Value (2018-2023)
  • The U.S. hGH Market by Indication (2018)
  • The U.S. Pediatric GH Market Forecast by Value (2018-2023)
  • The U.S. Pediatric GH Market by Indication (2018)
  • The U.S. Pediatric GHD Market Forecast by Value (2018-2023)
  • The U.S. Other Pediatric Indications Market Forecast by Value (2018-2023)
  • The U.S. Adult GHD Market Forecast by Value (2018-2023)
  • The U.S. Adult GHD Market Forecast by Value (2018-2023)
  • The U.S. Pediatric GHD Patient Population Forecast (2018-2023)
  • The U.S. Pediatric GHD Patient Population by Type (2018)
  • The U.S. TransCon Revenue Forecast (2021-2028)
  • Europe hGH Market Forecast by Value (2018-2023)
  • Europe hGH Market by Indication (2018)
  • Europe Pediatric GHD Patient Population Forecast (2018-2023)
  • Europe Pediatric GHD Patient Population by Type (2018)
  • Europe TransCon Revenue Forecast (2023-2028)
  • Japan hGH Market Forecast by Value (2018-2023)
  • Japan hGH Market by Indication (2018)
  • Japan Pediatric GHD Patient Population Forecast (2018-2023)
  • Japan Pediatric GHD Patient Population by Type (2018)
  • Japan TransCon Revenue Forecast (2023-2028)
  • Global New Cancer Patients by Volume (2014-2018)
  • Global GDP Per Capita (2014-2018)
  • Global Spending on Medicines (2010-2022)
  • Global Healthcare Expenditure (2014-2018)
  • Global Late Stage Long-Acting Growth Hormone in Progress (2018)
  • Average Annual Cost of hGH Therapy for Children and Adults
  • Global hGH Market Volume Share by Company (2018)
  • The U.S. hGH Market Value Share by Company (2018)
  • Novartis International AG Sales by Segment (2018)
  • Novartis Net Sales and Net Income (2014-2018)

List of Tables

  • The U.S. Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2019-2024)
  • EU Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2019-2024)
  • Japan Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2020-2024)
  • The U.S., Europe & Japan/ROW Growth Hormone Deficiency Market of TransCon hGH (2021-2024)
  • Clinical Development Timeline for TransCon hGH (2018)
  • Global Late Stage Long-Acting Growth Hormone in Progress (2018)
  • Average Annual Cost of hGH Therapy for Children and Adults
  • Global Long-Acting Growth Hormone Landscape by Company (2018)
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Eli Lilly and Company
  • Novartis International AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4758509
Adroll
adroll